Gastrointestinal stromal tumors

Abdom Imaging. 2006 Jul-Aug;31(4):387-99. doi: 10.1007/s00261-004-0092-8. Epub 2006 Feb 7.

Abstract

Background: We reviewed radiologic features of gastrointestinal stromal tumors (GISTs) and correlated them with clinical and pathologic findings.

Methods: We investigated a series of 39 c-Kit-positive GISTs. Clinical and radiologic findings and management of these patients were recorded.

Results: Twenty women and 19 men (mean age 64 years) had histologically proved GIST. Tumor locations were the small bowel (n = 20), stomach (n = 14), rectum (n = 4), and omentum (n = l). Symptoms at presentation were most frequently gastrointestinal bleeding (n = 14) and abdominal pain (n = l1). Tumors were classified as very low risk (n = 2), low risk (n = 10), intermediate risk (n = 12), and high risk (n = 11). Ultrasonography, computed tomography, magnetic resonance, digital subtraction angiography, and barium series were used in the evaluation of these tumors. Most tumors were seen as well-delineated soft tissue masses with heterogeneous contrast enhancement. Necrosis, calcification, and ulceration were most commonly seen in large tumors that presented a more aggressive behavior.

Conclusion: GISTs can arise anywhere in the gastrointestinal tract and present a great variety of clinical and radiologic features, depending mostly on size and location.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Barium Sulfate
  • Benzamides
  • Contrast Media
  • Female
  • Gastrointestinal Stromal Tumors / diagnosis*
  • Gastrointestinal Stromal Tumors / pathology
  • Gastrointestinal Stromal Tumors / therapy
  • Humans
  • Imatinib Mesylate
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Palliative Care
  • Piperazines / therapeutic use
  • Pyrimidines / therapeutic use
  • Retrospective Studies
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • Antineoplastic Agents
  • Benzamides
  • Contrast Media
  • Piperazines
  • Pyrimidines
  • Barium Sulfate
  • Imatinib Mesylate